eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Opłaty publikacyjne
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
NOWOŚĆ
Portal dla gastroenterologów!
www.egastroenterologia.pl
SCImago Journal & Country Rank
3/2021
vol. 16
 
Poleć ten artykuł:
Udostępnij:
Artykuł oryginalny

Patterns and grades of presentation of colon cancer in Northern Saudi Arabia

Saleh H Alharbi
1
,
Khalil I Alshammari
1
,
Khulaif Khalaf Alanazi
2
,
Hussain Gadelkarim Ahmed
2, 3

  1. Department of Internal Medicine, Al Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia
  2. Department of Pathology, College of Medicine, University of Ha’il, Saudi Arabia
  3. Department of Histopathology and Cytology, FMLS, University of Khartoum, Sudan
Gastroenterology Rev 2021; 16 (3): 235–239
Data publikacji online: 2021/03/05
Plik artykułu:
- Patterns and grades.pdf  [0.18 MB]
Pobierz cytowanie
 
Metryki PlumX:
 

Introduction

Colorectal cancer (CRC) represents the third most common cancer and the second leading cause of cancer-related death worldwide [1]. The CRC is responsible for significant incidence rates of global cancer-related morbidity and morbidity. Although colon screening programs have reduced the incidence rates in several parts of the world, the mortality is still rising in some parts of the world [2, 3]. Many risk factors have been implicated in the aetiology of CRC, including dietary [4], environmental [5], and genetic factors [6].

CRC is highly preventable if powerful prevention strategies are implemented, including lifestyle changes, screening the at-risk population, and widespread public primary prevention strategies. Substantial progress in CRC prevention can be strengthened by the design of new screening policies, positioning the accessible CRC screening models to enhance the outcomes while ensuring sensible expenditure of assets [7].

There is a lack of epidemiological data on CRC, although early studies indicated it as the commonest cancer among men and the third most common cancer among women in Saudi Arabia. The disease tends to affect the younger generation, particularly women. Most cases present with advanced stages of the disease, denoting the lack of screening or public awareness towards early detection [8, 9]. Several studies from Saudi Arabia have claimed a low level of awareness towards CRC prevention, screening, and early diagnosis [10, 11], which revealed patients seeking help at the late stages of the disease.

Aim

Consequently, the present study aimed to determine the patterns and stages of colon cancer presentation in Northern Saudi Arabia.

Material and methods

Retrieved data and tissue blocks related to 50 colorectal patients from King Khalid Hospital, Hai’l province, Northern Saudi Arabia were used in the study. The sample represented all available colorectal specimens (full coverage cancer cases within 10 years). The retrieved data included a full histopathology report, gender, and age. All tissues were retrieved in the form of formalin-fixed paraffin wax processed blocks. The tissues were found to be obtained in the form of colonoscopy or/and biopsy. All tissue blocks were sectioned and stained using haematoxylin and eosin method to confirm the prior diagnosis. The histopathological assessment process role was achieved by offering a pathological classification category considering the histological type of malignancy and differentiation stage. The categorization of conventional adenocarcinoma was achieved by glandular formation. Invasive carcinoma is categorized by invading cancer cells through mascularis mucosa into the submucosa, as well as the presence of desmoplastic reactions. Grading of moderately differentiated adenocarcinoma was stated when glandular formation accounted for 50–95%. Poorly differentiated adenocarcinoma was stated when glandular construction accounted for < 50%, and most lesions revealed concrete patterns.

Statistical analysis

All retrieved variables were entered into the computer software Statistical Package for Social Sciences (SPSS) and then analysed to obtain frequencies, percentages, cross-tabulations, χ2 test, and odds ratios (OR). Considering a 95% confidence interval, a p-value less than 0.05 was considered statistically significant.

Results

The 50 studied cases (41 (82%) Saudi and 9 (18%) non-Saudi) included 28 (56%) males and 22 (44%) females, aged 29 to 86 years with a mean age ± STD of 58.6 ±1.29 years. The male: female ratio was 1.27 : 1.00, as shown in Table I and Figure 1.

Table I

Distribution of patients by nationality, age, and gender

VariableMalesFemalesTotal
Nationality:
Saudi231841
Non-Saudi549
Total282250
Age group [years]:
< 507310
50–598614
60–6951015
≥ 708311
Total282250
Figure 1

Description of patients by nationality, age, and gender

/f/fulltexts/PG/43413/PG-16-43413-g001_min.jpg

The diagnosed colon cancers included conventional adenocarcinoma 36 (72%), mucinous adenocarcinoma 4 (8%), carcinoma-in-situ 4 (8%), and invasive adenocarcinoma 6 (12%). Moderately differentiated and poorly differentiated stages were confirmed in 46 (92%) and 4 (8%), respectively, as shown in Figure 2.

Figure 2

Description of patients by histopathological features

/f/fulltexts/PG/43413/PG-16-43413-g002_min.jpg

Conventional adenocarcinoma was presented equally in both sexes. Mucinous adenocarcinoma was more frequent among females 3 (75%), whereas carcinoma in situ 4 (100) and invasive adenocarcinoma 5 (83%) were more common among males. Males and females have a similar grade of presentation (moderately differentiated); hence, poorly differentiated grade was commonly seen in males 3 (75%), as indicated in Table II and Figure 3.

Table II

Distribution of the histopathological diagnosis by gender and nationality

DiagnosisMales (n = 28)Females (n = 22)Total (n = 50)Saudi (n = 41)Non-Saudi (n = 9)
Conventional adenocarcinoma181836315
Mucinous adenocarcinoma13431
Carcinoma in-situ40422
Invasive adenocarcinoma51651
Moderately differentiated252146379
Poorly differentiated31440
Figure 3

Distribution of the histopathological diagnosis by gender and nationality

/f/fulltexts/PG/43413/PG-16-43413-g003_min.jpg

Most cases of conventional adenocarcinoma were found among age ranges 60–69 years followed by < 50 years, representing 12/36 (33%) and 9/36 (25%), respectively. All cases of mucinous adenocarcinoma were found in the range 50–69 years (4 (100%)). The cases with poorly differentiated carcinoma were frequently seen in the age range ≥ 70 years (3 (75%)), as indicated in Table III, Figures 46.

Table III

Distribution of the histopathological diagnosis by gender and age

Diagnosis< 50 years50–59 years60–69 years≥ 70 yearsTotal
Conventional adenocarcinoma9812736
Mucinous adenocarcinoma02204
Carcinoma in-situ02024
Invasive adenocarcinoma12126
Moderately differentiated91414946
Poorly differentiated10124
Figure 4

Distribution of the histopathological diagnosis by gender and age

/f/fulltexts/PG/43413/PG-16-43413-g004_min.jpg
Figure 5

Colon adenocarcinoma (H&E, 100×)

/f/fulltexts/PG/43413/PG-16-43413-g005_min.jpg
Figure 6

Colon adenocarcinoma (H&E, 100×)

/f/fulltexts/PG/43413/PG-16-43413-g006_min.jpg

Discussion

The present study’s findings indicate that many Saudi Arabian patients present with colon cancer at an early age with advanced stages of the disease, and men were more frequently affected than females. About 20% of the patients presented at age < 50 years, which is globally considered younger age [12], and most of them were males. However, several factors might contribute to the overall increased prevalence of this condition, such as lack of physical activity, dietary factors, and obesity; however, the increased prevalence among the younger generation may stimulate thinking about a better understanding of the genetic processes underlying the disease in this population. Such approaches may offer the opportunity of establishing evidence-based strategies for screening and clinical management for better outcomes in this section of the population [13]. Factors such as race and tumour biology have been suggested to contribute to the diversity of colon cancer in all ages [14, 15]. Moreover, it is well established that colon cancer is more frequent among males [14].

In the present study, all of the colon lesions were adenocarcinomas, with predominantly revealed conventional adenocarcinoma. This is in agreement with the available facts in the literature stating that the adenocarcinoma variant represents more than 90% of colorectal carcinomas [16]. However, a mucinous variant was identified in 8% of the cases in the present series. Mucinous adenocarcinoma of the colon represents a variant with worse survival outcomes than other variants [17]. This type of colon cancer is identified by a large amount of extracellular mucin (approximately 50% of the tumour bulk). Mucinous adenocarcinoma represents 10% to 20% of CRC. It is more frequently seen in younger females [18], which is supported by the findings of the present study’s findings (75% of the patients with mucinous adenocarcinoma were females, and about 50% were aged less than 60 years).

About 92% of the cases were categorized as moderately differentiated tumours, and the remaining 8% of patients were found to have poorly differentiated lesions. About 70% of colorectal adenocarcinoma are identified in moderately differentiated grades, whereas poorly differentiated represents 10% to 20% of the diagnosed CRC cases [19]. However, studies from Saudi Arabia have shown that more than 70% of cases of colorectal cancers are diagnosed at the late stages of the diseases, indicating the ineffectiveness of the screening and other control measures in the country [20, 21]. A study from North West Saudi Arabia has shown that most of the patients with CRC presented with intestinal obstruction, and there were more younger patients than older patients, and females were more frequent than males, which is in line with the findings of the present study [22]. These findings necessitate urgent intervention of national policies to detect small cancers and precancer by implementing sustainable screening programs to identify patients at risk. This will ultimately reduce the number of cases presenting with advanced stages of CRC in the country [23].

Althought the present study has some limitations, including its small sample size and its retrospective setting, it provides valuable information for health policymakers and health providers in the course of overall colorectal cancer management in Saudi Arabia. Moreover, the study clarified the areas for future research in environmental and genetic associated clues of colorectal cancer.

Conclusions

Conventional adenocarcinoma is the most common presenting colon cancer, and at a relatively young age. Mucinous adenocarcinoma frequently presents in female patients of a somewhat more youthful generation. Most patients are diagnosed with moderately differentiated adenocarcinoma, followed by poorly differentiated adenocarcinoma. The findings necessitate urgent intervention of national policies for early detection by implementing sustainable screening programs.

Acknowledgments

Authors would like to thank to thank the people at King Khalid Hospital for their help in data collection as well as, the Scientific Research Deanship at the University of Ha'il – Saudi Arabia, for funding through project number RG-20009.

Conflict of interest

The authors declare no conflict of interest.

References

1 

Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors, and prevention strategies. Nat Rev Gastroenterol Hepatol 2019; 16: 713-32.

2 

Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer. Lancet 2019; 394: 1467-80.

3 

Issa IA, Noureddine M. Colorectal cancer screening an updated review of the available options. World J Gastroenterol 2017; 23: 5086-96.

4 

Ocvirk S, Wilson AS, Appolonia CN, et al. Fiber, fat, and colorectal cancer: new insight into modifiable dietary risk factors. Curr Gastroenterol Rep 2019; 21: 62.

5 

Song M, Chan AT, Sun J. Influence of the gut microbiome, diet, and environment on risk of colorectal cancer. Gastroenterology 2020; 158: 322-40.

6 

Kastrinos F, Samadder NJ, Burt RW. Use of family history and genetic testing to determine risk of colorectal cancer. Gastroenterology 2020; 158: 389-403.

7 

Ladabaum U, Dominitz JA, Kahi C, Schoen RE. Strategies for colorectal cancer screening. Gastroenterology 2020; 158: 418-32.

8 

Alsanea N, Abduljabbar AS, Alhomoud S, et al. Colorectal cancer in Saudi Arabia: incidence, survival, demographics and implications for national policies. Ann Saudi Med 2015; 35: 96-202.

9 

Alqahtani WS, Almufareh NA, Domiaty DM, et al. Epidemiology of cancer in Saudi Arabia thru 2010-2019: a systematic review with constrained meta-analysis. AIMS Public Health 2020; 7: 679-96.

10 

Al-Hajeili M, Abdulwassi HK, Alshadadi F, et al. Assessing knowledge on preventive colorectal cancer screening in Saudi Arabia: a cross-sectional study. J Family Med Prim Care 2019; 8: 3140-6.

11 

Alshammari SA, Alenazi HA, Alshammari HS. Knowledge, attitude, and practice towards early screening of colorectal cancer in Riyadh. J Family Med Prim Care 2020; 9: 2273-80.

12 

Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors, and prevention strategies. Nat Rev Gastroenterol Hepatol 2019; 16: 713-32.

13 

Connell LC, Mota JM, Braghiroli MI, Hoff PM. The rising incidence of younger patients with colorectal cancer: questions about screening, biology, and treatment. Curr Treat Options Oncol 2017; 18: 23.

14 

Hanna K, Zeeshan M, Hamidi M, et al. Colon cancer in the young: contributing factors and short-term surgical outcomes. Int J Colorectal Dis 2019; 34: 1879-85.

15 

Pardini B, Corrado A, Paolicchi E, et al. DNA repair and cancer in colon and rectum: novel players in genetic susceptibility. Int J Cancer 2020; 146: 363-72.

16 

Hamilton SR, Bosman FT, Boffetta P, et al. Carcinoma of the colon and rectum. In: WHO Classification of Tumours of the Digestive System. Bosman FT, Carneiro F, Hruban RH, Theise ND, eds. Lyon: IARC Press 2010: 134-46.

17 

Fields AC, Lu P, Goldberg J, et al. The role of adjuvant chemotherapy in stage II and III mucinous colon cancer. J Surg Oncol 2019; 120: 1190-200.

18 

Luo C, Cen S, Ding G, Wu W. Mucinous colorectal adenocarcinoma: clinical pathology and treatment options. Cancer Commun 2019; 39: 13.

19 

Fleming M, Ravula S, Tatishchev SF, Wang HL. Colorectal carcinoma: pathologic aspects. J Gastrointest Oncol 2012; 3: 153-73.

20 

Alyabsi M, Alhumaid A, Allah-Bakhsh H, et al. Colorectal cancer in Saudi Arabia as the proof-of-principle model for implementing strategies of predictive, preventive, and personalized medicine in healthcare. EPMA J 2019; 11: 119-31.

21 

Bakarman MA, AlGarni AM. Colorectal cancer patients in western Saudi Arabia. Outcomes and predictors for survival over a 10-years period (2002-2014). Saudi Med J 2019; 40: 1227-34.

22 

Albalawi IA, Abdullah AA, Mohammed ME. Emergency presentation of colorectal cancer in Northwestern Saudi Arabia. Saudi Med J 2017; 38: 528-33.

23 

Aljumah AA, Aljebreen AM. Policy of screening for colorectal cancer in Saudi Arabia: a prospective analysis. Saudi J Gastroenterol 2017; 23: 161-8.

Copyright: © 2021 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
© 2024 Termedia Sp. z o.o.
Developed by Bentus.